3YP-38571-07203
2 vaccinations
0 coded responses
2 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 763 / TX
- Registered
- 2021-03-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-26
Dose 1 — Pfizer-BioNTech
-
2021-03-19
Dose 2 — Pfizer-BioNTech
-
2021-03-23
Registered in v-safe
- 2021-03-23
-
2021-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache · Be unable to workAdult check-in
- 2021-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Pfizer-BioNTech | |
| 2 | 2021-03-19 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-24 | priority 2/3 |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.